Patanjali Foods Ltd Share Price (PATANJALI)

Patanjali Issues Apology for Misleading Advertisements - 24 Apr, 2024

Yoga guru Baba Ramdev and his associate Balkrishna issued a renewed apology in major newspapers for the misleading advertisements of Patanjali's medicinal products. The Supreme Court is examining Patanjali Ayurved's misleading advertisements and has broadened its scrutiny to include misleading advertisements by Fast-Moving Consumer Goods (FMCG) companies.

Patanjali Ayurved Misleading Ads Case Expands in Supreme Court - 23 Apr, 2024

The Indian Supreme Court has expanded the ongoing case against Patanjali Ayurved for misleading advertisements. The court has directed Union ministries and authorities to take action against FMCG companies indulging in false campaigns that affect vulnerable groups such as children and the elderly. Additionally, Patanjali Foods has incorporated two new subsidiaries.

Patanjali Foods incorporates two subsidiaries to improve farming - 22 Apr, 2024

Patanjali Foods has incorporated two wholly owned subsidiaries, Contemporary Agro and Rishikrishi Farming, in India with the objective of improving all types of farming, agriculture, and plantation. The companies aim to provide training to farmers and produce high-quality seeds for fruits, vegetables, and grains.

Patanjali Foods' ROCE Underperforms Industry Average - 21 Apr, 2024

Despite a 101% return for long-term shareholders in the last three years, Patanjali Foods' ROCE has remained flat at around 10%, underperforming the industry average of 15%. The company's investments have not provided high returns on capital, making it unlikely to be a multi-bagger from here.

Patanjali Foods Shares Rise as GQG Partners Increases Stake - 16 Apr, 2024

Investment management firm, GQG Partners, has increased its stake in Patanjali Foods from 3.3% to 11.48% at the end of Q4 FY24. The stock gained nearly 7% on this news and has risen 45% in a year. Additionally, Patanjali's promoters apologized to the Supreme Court for running ads that spread misinformation.

Patanjali Foods Reports Modest Growth in Q4 Revenue - 15 Apr, 2024

Patanjali Foods reported a modest single-digit growth in Q4 revenue from its edible oil segment and high-single digit growth in food & FMCG segments. The company is realigning its product portfolio towards healthier options. The stock dropped by over 3.80% on BSE.

Patanjali Foods Maintains Stable Revenue and EBITDA Margin - 14 Apr, 2024

Patanjali Foods' edible oil segment revenue showed modest single-digit growth, with stable EBITDA margin. Food & FMCG business accounted for over 30% of revenue from operations. Strategically realigning portfolio to cater to evolving consumer preferences.

Patanjali Ordered to Stop Promoting Products by Supreme Court - 10 Apr, 2024

The Indian Medical Association filed a case against Patanjali Ayurved for false claims about curing certain diseases. The Supreme Court has ordered Patanjali Ayurved to stop promoting ayurvedic products that claim to cure critical illnesses like heart issues and asthma. Baba Ramdev and Acharya Balkrishna have submitted affidavits offering unconditional apologies.

Patanjali Founders Apologize to Supreme Court - 09 Apr, 2024

Baba Ramdev and Acharya Balkrishna, founders of Patanjali Foods Ltd, have submitted an unconditional apology to the Supreme Court for flouting earlier orders and continuing to propagate misleading claims about curing diseases with their products.

Patanjali Accused of Disseminating Misinformation About Allopathy - 08 Apr, 2024

The Indian Medical Association has accused Patanjali of consistently disseminating misinformation to denigrate allopathy and making exaggerated claims about the efficacy of its own drugs, violating regulations. The IMA had approached the courts against a Patanjali advertisement titled 'Misconceptions spread by allopathy: Save yourself and the country from the misconceptions spread by pharma and medical industry.'

Baba Ramdev and Patanjali MD Summoned by Supreme Court - 02 Apr, 2024

The Supreme Court has summoned Baba Ramdev and Acharya Balkrishna of Patanjali Ayurved to explain why contempt proceedings should not be initiated for violating orders prohibiting advertisements claiming to cure diseases. The hearing is scheduled for April 2.